Clinical studies

Istituto Helvetico Sanders’ treatments are not on the market, they are exclusively sold in the trichological centres

All anti-hair loss and baldness products fully satisfy the legal requirements – Regulation (EC) No 1223/2009 f the European Parliament and the Council of 30 November 2009 on cosmetic products – from 11 July 2013, this Regulation will replace the “Cosmetics Directive” which until now has ensured that products circulate freely whilst guaranteeing a high level of protection for consumers.

The provisions of the Regulation aim at ensuring that consumers’ health is protected and that they are well informed by monitoring the composition and labelling of products. The Regulation also provides for the assessment of product safety and the prohibition of animal testing.

The efficacy of anti-hair loss and baldness products is tested with independent clinical studies commissioned to Italian Universities and dermo-cosmetic research’s laboratories. All treatments are hypoallergenic. Efficacy blind test are performed on healthy subjects, suffering from various stages of alopecia; efficacy test with different samples – menopausal women, for example – versus placebo, in order to verify the efficacy for subjects in specific conditions, or to assess the impact of the hygienic phase and/or nutrition integration on the trichological treatment’s results. Clinical studies are performed in accordance with Helsinki Declaration.

The World Medical Association (WMA)  developed the Declaration of Helsinki as a treat of ethical principles for medical research involving human subjects including research on identifiable human material and data.